title: Molecular deciphering of the ABO system as a basis for novel diagnostics and therapeutics in ABO incompatible transplantation.
abstract: In recent years ABO incompatible kidney transplantation (KTx) has become a more or less clinical routine procedure with graft and patient survival similar to those of ABO compatible transplants. Antigen-specific immunoadsorption (IA) for anti-A and anti-B antibody removal constitutes in many centers an important part of the treatment protocol. ABO antibody titration by hemagglutination is guiding the treatment; both if the recipient can be transplanted as well as in cases of suspected rejections if antibody removal should be performed. Despite the overall success of ABO incompatible KTx, there is still room for improvements and an extension of the technology to include other solid organs. Based on an increased understanding of the structural complexity and tissue distribution of ABH antigens and the fine epitope specificity of the ABO antibody repertoire, improved IA matrices and ABO antibody diagnostics should be developed. Furthermore, understanding the molecular mechanisms behind accommodation of ABO incompatible renal allografts could make it possible to induce long-term allograft acceptance also in human leukocyte antigen (HLA) sensitized recipients and, perhaps, also make clinical xenotransplantation possible.
authors.affiliation: 1Department of Clinical Chemistry and Transfusion Medicine and.
authors.forename: Jan
authors.initials: J
authors.lastname: Holgersson
authors.forename: Lennart
authors.initials: L
authors.lastname: Rydberg
authors.forename: Michael E
authors.initials: ME
authors.lastname: Breimer
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology*; D001787:Blood Group Incompatibility / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy; D003888:Desensitization, Immunologic / Q000379:methods / Q000639:trends; D006084:Graft Rejection / Q000209:etiology / Q000276:immunology* / Q000628:therapy; D006085:Graft Survival / Q000276:immunology; D006801:Humans; D016377:Organ Transplantation / Q000009:adverse effects / Q000379:methods*
chemical_list: D000017:ABO Blood-Group System
keywords: ABO blood group system; blood group ABH antigens; blood group ABO antibodies; carbohydrate antigens; glycoengineering; mucins; transplantation